News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Nizar Jacques Bahlis: The most comprehensive AI assisted individualized risk classifier in Multiple Myeloma
Photo taken from Nizar Jacques Bahlis/Twitter
Jan 14, 2024, 17:31

Nizar Jacques Bahlis: The most comprehensive AI assisted individualized risk classifier in Multiple Myeloma

Nizar Jacques Bahlis, Associate Professor at the Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, shared on X:

“‘Precognition’ in myeloma.

The most comprehensive AI assisted individualized risk classifier in MM Journal of Clinical Oncology by Francesco Maura, Sylvester Comprehensive Cancer Center. In addition to clinical features prediction model accounts for 20 genomic features including APOBEC.”

Nizar Jacques Bahlis: The most comprehensive AI assisted individualized risk classifier in Multiple Myeloma

Read further.
Source: Nizar Jacques Bahlis/X

'Precognition' in myeloma cancer Francesco Maura Journal of Clinical Oncology Myeloma Nizar Jacques Bahlis OncoDaily Oncology Sylvester Comprehensive Cancer Center
Special Coverage
Insight
Sep 4, 2025, 20:03
Aruni Ghose: AI-Enhanced Medical Imaging for Cancer Diagnosis
Insight
Sep 4, 2025, 19:35
A Reminder That Education Is Essential to Patient Care - Elekta
Dialogues
Sep 4, 2025, 18:19
MASCC 2025 Presidential Training Fellowship Spotlight: Dr. Colleen Ann Cuthbert
Immune Oncology
Sep 4, 2025, 16:49
LIBRETTO-431 East Asia Subgroup Results of First-line Selpercatinib vs Chemotherapy + Pembrolizumab in RET Fusion–Positive NSCLC
OncoDaily Pulse
Sep 4, 2025, 16:17
Mariam Sargsyan: Meet the Experts of VIRO 2025
OncoDaily Pulse
Sep 4, 2025, 16:08
Elizabeth Wulff-Burchfield: Meet the Experts of VIRO 2025
Voices
Sep 4, 2025, 15:59
Markus Kosch: Finding Strength After Diagnosis - A Conversation with Claudia Poguntke
Voices
Sep 4, 2025, 15:59
Common Sense Oncology India Hub Webinar – Insights on the MATTERHORN Trial
Voices
Sep 4, 2025, 15:56
Servier and IDEAYA Biosciences Partner to Advance Darovasertib for Uveal Melanoma
Voices
Sep 4, 2025, 15:55
Bridging Divides, Building Futures at the 2025 World Cancer Leaders’ Summit - UICC
Insight
Sep 4, 2025, 15:51
Christine Maheu: Systematic Review of Fear of Cancer Recurrence Measures 
Voices
Sep 4, 2025, 15:49
Svetlana Nikic: My Journey in Precision Oncology